Vassilis Georgoulias

30PUBLICATIONS
71CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPacific Peoples cultural determinants of healthInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 12, 2026
<i>AXL</i>-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer.

|May 27, 2026
Fibroblast Activation Protein Inhibitor (FAPI) PET: A Scoping Review of Emerging Oncologic and Fibroinflammatory Applications.

|May 13, 2026
The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic Strategies.

|May 04, 2026
Determinants of Chemotherapy Convenience and Satisfaction: The Role of Symptom and Psychological Burden in Cancer Patients-A Cross-Sectional Study.

|Feb 18, 2026
Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Karolina Mangani, Evangelia Pantazaka, Evi Lianidou

|Jan 28, 2026
Combinatorial Analysis of CD4<sup>+</sup>Tregs, CD8<sup>+</sup>Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC Patients.

Anastasia Xagara, Konstantinos Tsapakidis, Vassileios Papadopoulos

Pageof 5

Frequent Collaborators

15 joint publications

Vassilis Georgoulias

11 joint publications

Evi S Lianidou

10 joint publications

Galatea Kallergi

9 joint publications

Anastasia Xagara